Zhende Medical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003J31
  • SHG: 603301
CNY
79.99
-0.31 (-0.39%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
1,223.65
1,000.41
1,145.34
1,084.06
1,108.63
991.56
1,138.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,223.65
1,000.41
1,145.34
1,084.06
1,108.63
991.56
1,138.50
Raw Material Cost
838.04
692.35
786.75
751.19
762.34
683.56
801.05
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7.58
8.13
6.45
11.80
7.82
5.41
4.81
Selling and Distribution Expenses
224.90
195.08
216.84
195.85
214.22
193.61
212.53
Other Expenses
2.55
2.13
3.54
2.29
2.13
2.70
3.05
Total Expenditure (Excl Depreciation)
1,096.04
916.86
1,045.45
981.77
1,005.72
909.57
1,048.87
Operating Profit (PBDIT) excl Other Income
127.6
83.6
99.9
102.30000000000001
102.89999999999999
82
89.60000000000001
Other Income
14.58
1.88
19.82
18.56
12.59
7.77
45.96
Operating Profit (PBDIT)
201.10
147.48
163.04
183.90
174.85
135.40
163.67
Interest
7.58
8.13
6.45
11.80
7.82
5.41
4.81
Exceptional Items
-0.84
11.53
-2.08
-2.08
1.29
3.51
-9.33
Gross Profit (PBDT)
385.61
308.07
358.59
332.87
346.30
308.01
337.44
Depreciation
85.04
85.04
77.80
77.80
71.61
71.61
54.43
Profit Before Tax
107.64
65.84
76.70
92.22
96.71
61.90
95.10
Tax
13.58
8.07
19.44
11.88
17.42
8.99
14.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
89.33
54.45
57.63
75.42
76.52
51.24
77.71
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
89.33
54.45
57.63
75.42
76.52
51.24
77.71
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
4.16
3.11
-1.07
4.47
1.72
1.17
2.03
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
93.49
57.56
56.56
79.89
78.25
52.41
79.74
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
5,676.32
5,724.96
5,686.73
5,702.97
5,631.97
5,707.99
5,643.25
Earnings per share (EPS)
0.34
0.21
0.22
0.28
0.29
0.19
0.29
Diluted Earnings per share
0.34
0.21
0.22
0.28
0.29
0.19
0.29
Operating Profit Margin (Excl OI)
8.29%
6.05%
5.71%
8.08%
8.18%
5.65%
5.56%
Gross Profit Margin
15.75%
15.08%
13.49%
15.68%
15.18%
13.46%
13.13%
PAT Margin
7.3%
5.44%
5.03%
6.96%
6.9%
5.17%
6.83%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 22.31% vs -12.65% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 62.33% vs 1.77% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 28.09% vs 1.68% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is -6.17% vs 24.62% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Zhende Medical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,223.65
0
1,223.65
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,223.65
0
1,223.65
Raw Material Cost
838.04
0
838.04
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
7.58
0
7.58
Selling and Distribution Expenses
224.90
0
224.90
Other Expenses
2.55
0.00
2.55
Total Expenditure (Excl Depreciation)
1,096.04
0
1,096.04
Operating Profit (PBDIT) excl Other Income
127.60
0.00
127.60
Other Income
14.58
0
14.58
Operating Profit (PBDIT)
201.10
0
201.10
Interest
7.58
0
7.58
Exceptional Items
-0.84
0
-0.84
Gross Profit (PBDT)
385.61
0
385.61
Depreciation
85.04
0
85.04
Profit Before Tax
107.64
0
107.64
Tax
13.58
0
13.58
Provisions and contingencies
0
0
0.00
Profit After Tax
89.33
0
89.33
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
89.33
0
89.33
Share in Profit of Associates
0
0
0.00
Minority Interest
4.16
0
4.16
Other related items
0.00
0.00
0.00
Consolidated Net Profit
93.49
0
93.49
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
5,676.32
0
5,676.32
Earnings per share (EPS)
0.34
0
0.34
Diluted Earnings per share
0.34
0
0.34
Operating Profit Margin (Excl OI)
8.29%
0%
0.00
8.29%
Gross Profit Margin
15.75%
0%
0.00
15.75%
PAT Margin
7.30%
0%
0.00
7.30%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 122.36 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 22.31% vs -12.65% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 10.37% vs 2.79% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 9.35 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 62.33% vs 1.77% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 19.57% vs -15.09% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18.65 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 28.09% vs 1.68% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 14.91% vs -5.86% in Jun 2025

Quarterly - Interest
Interest 0.76 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -6.17% vs 24.62% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -2.56% vs 0.00% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.29%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Footer loading